Biocryst Pharmaceuticals BCRX
NASDAQ BCRX
$8.17 +0.05 (+0.62%)
At close: Oct 2, 2026 · 4:00 PM EDT

Biocryst Pharmaceuticals (BCRX) Interest & Investment Income (2010 - 2026)

Updated

Biocryst Pharmaceuticals' Interest & Investment Income came in at $2.43 million for Q2 2026, down 3.3% from $2.52 million a year earlier but up 7.9% from the prior quarter.

Analysis

Biocryst Pharmaceuticals (BCRX) Interest & Investment Income (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Biocryst Pharmaceuticals reported Interest & Investment Income of $9.82 million, down 22.7% year-over-year; for FY2025, it was $10.67 million, down 27.7% from FY2024.

  • Interest & Investment Income carries a five-year compound annual growth rate of 2.5% (FY2020 to FY2025).
  • Going back by year, Interest & Investment Income was $14.75 million in FY2024 (-6.5%), $15.78 million in FY2023 (+207.7%), $5.13 million in FY2022 and $62,000 in FY2021 (-99.3%).
  • The five-year range for quarterly Interest & Investment Income is $9,000 (Q3 2021) to $4.47 million (Q4 2023).
  • Year-over-year, Interest & Investment Income has declined for nine consecutive quarters, with an average decline of 21.7% over the last eight quarters.
  • The fastest year-over-year change in Interest & Investment Income over five years came in Q2 2023 (growth of 515.8%), and the weakest in Q4 2021 (a decline of 97.3%).
  • Business Quant data shows BCRX's Interest & Investment Income at $2.26 million (Q1 2026), $2.89 million (Q4 2025) and $2.24 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Biocryst Pharmaceuticals 2.09 Bn 1.01 Bn 214.41 Mn 2.43 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.43 Mn
Mar 31, 2026 2.26 Mn
Dec 31, 2025 2.89 Mn
Sep 30, 2025 2.24 Mn
Jun 30, 2025 2.52 Mn
Mar 31, 2025 3.02 Mn
Dec 31, 2024 3.57 Mn
Sep 30, 2024 3.59 Mn
Jun 30, 2024 3.55 Mn
Mar 31, 2024 4.03 Mn
Dec 31, 2023 4.47 Mn
Sep 30, 2023 4.18 Mn
Jun 30, 2023 3.75 Mn
Mar 31, 2023 3.38 Mn
Dec 31, 2022 2.70 Mn
Sep 30, 2022 1.76 Mn
Jun 30, 2022 609,000.00
Mar 31, 2022 54,000.00
Dec 31, 2021 14,000.00
Sep 30, 2021 9,000.00
API Access

Biocryst Pharmaceuticals Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=BCRX&period=max&api_key=YOUR_API_KEY